MedPath

Homeopathic Cold Medicine for Children

Not Applicable
Completed
Conditions
Upper Respiratory Tract Infection
Interventions
Drug: Hyland's Cold 'n Cough 4 Kids
Registration Number
NCT00858494
Lead Sponsor
University of Washington
Brief Summary

The purpose of this study is to determine if a commercially available homeopathic cold remedy for children is effective in providing relief from cold symptoms in children 2-5 years old. It is postulated that children will have relief of symptoms after receiving a dose of the cold remedy

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Children 24-59 months old
  • Cold/cough symptoms of <7 days duration
  • Diagnosed with upper respiratory tract infection by physician or nurse practitioner
  • Parent who speaks and reads English
Read More
Exclusion Criteria
  • Use of chronic medication other than multivitamins
  • History of asthma
  • Medication other than acetaminophen or ibuprofen
  • Use of homeopathic remedy within preceding 30 days
  • Only 1 participant per family
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
homeopathic cold remedyHyland's Cold 'n Cough 4 Kids-
Primary Outcome Measures
NameTimeMethod
Relief of Upper Respiratory Tract Infection (URI) Symptoms (Cough, Runny Nose, Nasal Congestion, Sneezing)1 Hour After Dose of Homeopathic Remedy.up to 10 days from index visit

For each dose of study medication, parents indicated which of the symptoms were present (runny nose, cough, nasal congestion, sneezing). Parents rated change in each symptom present one hour after a dose of study medication for up to 6 doses in study logs. Responses were dichotomized as at least some improvement or better (improvement) vs. no improvement or worse. The outcome measure is number of times that improvement in a specific symptom was noted after a dose of the homeopathic remedy. Completed study logs were received from 37 of 49 enrolled participants.

Secondary Outcome Measures
NameTimeMethod
Parental Report of an Adverse Event After a Dose of Study Medicationdata collected after doses occurring up to 10 days after index visit

After each dose of study medication parents reported the presence of any adverse events

Trial Locations

Locations (1)

University of Washington Medical Center-Roosevelt Pediatric Care Center

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath